ACO Name and Location

McLaren High Performance Network, LLC
2701 Cambridge Court Suite 200
Auburn Hills, Michigan 48326

ACO Primary Contact

Primary Contact Name

Scott Johnson

Primary Contact Phone Number

800-822-4950

Primary Contact Email Address

scott.johnson@mclaren.org

Organizational Information

ACO participants:


ACO Participants

ACO Participant in Joint Venture (Enter Y or N)

Michael Swords Do Pllc

Y

Thomas C Hosey Dpm & Associates Pc

Y

Barbara Ann Karmanos Cancer Hospital

Y

Lynn L Mathia DO

Y

J Wesley Mesko Md Pc

Y

Charles J Taunt Jr Do Pc

Y

Najjar Infectious Disease PC

Y

Northern Michigan Medical Management

Y

Michael A Kia Do Pc

Y

Surgical Consultants PLLC

Y

Lapeer Pediatrics PC

Y

Jason Cochran Do Pc

Y

Esa M Ali MD PC

Y

Cardiac Institute

Y

Raouf Mikhail

Y

Laura Lucio-Reincke, Pllc

Y

Looking Glass Foot & Ankle Pc

Y

Northern Michigan Hematology And Oncology

Y

John Ketner

Y

Mount Clemens Regional Medical Center

Y

McLaren Port Huron

Y

Central Michigan Community Hospital

Y

Pontiac Osteopathic Hospital

Y

Ingham Regional Medical Center

Y

Kellam & Associates, P. C.

Y

Gladstone A Payton DO PC

Y

Bay Regional Medical Center

Y

Capital Area Anesthesia PC

Y

McLaren Northern Michigan

Y

Singh & Arora Oncology Hematology PC

Y

Vascular Surgery Assoc PC

Y

Preecha Supanwanid, Md Pc

Y

Capital Internal Medicine Associates PC

Y

McLaren Regional Medical Center

Y

Pulmonary & Critical Care Medicine Consultants Pc

Y

Orthopedic Associates of Port Huron PC

Y

John Ketner

Y

Raouf Mikhail

Y

Pulmonary Associates PC

Y

Lapeer Regional Medical Center

Y

Anup Sud MD PC

Y

Northeast Surgical Group PC

Y

Hampton Medical Center PC

Y

Hesham E Gayar MD PC

Y

McLaren Medical Group

Y

Northpointe OB-GYN PC

Y

Mid-Michigan Physicians PC

Y

Gary E Hosey DPM PC

Y

Pain Management Centers PC

Y

Cynthia L Glasson Inc

Y

Michigan Cardiology PC

Y

Petoskey Family Medicine PC

Y

Michael J Mueller Md Pc

Y

Northern Michigan Pain Specialists PC

Y

John D Arsen DPM Inc

Y

MEDPARTNERS PLC

Y

Michigan State University

Y

Mt Morris Medical Group Pllc

Y

Heart & Vascular Institute of MI PC

Y

Larkin Family Medicine PLC

Y

Family First - Armada PLLC

Y

Mount Pleasant Medical Associates PLLC

Y

John N Flood Do Pc

Y

Foremost Podiatry Pc

Y

Patrick H Noud Md Plc

Y

Frederick R Armenti MD PC

Y

Chest And Sleep Medicine Consultants,Plc

Y

ACO governing body:


Member

Member's Voting Power

Membership Type

ACO Participant TIN Legal Business Name/DBA, if Applicable

Last Name

First Name

Title/Position

McKenna

Michael

Chairman

1

ACO Participant Representative

McLaren Northern Michigan

Ropp

Brad

Voting Member

1

ACO Participant Representative

Ingham Regional Medical Center

Kendall

Kathy

Voting Member

1

Other – McLaren Health Plan, CEO

N/A

Mazurkiewicz

David

Voting Member

1

ACO Participant Representative

Mount Clemens Regional Medical Center

Wentzloff

Gary

Voting Member

1

ACO Participant Representative

Central Michigan Community Hospital

Ziccardi

Michael

Voting Member

1

ACO Participant Representative

McLaren Regional Medical Center

Cowsill

Lawrence

Voting Member

1

ACO Participant Representative

Pontiac Osteopathic Hospital

Lee

Daniel

Voting Member

1

ACO Participant Representative

Bay Regional Medical Center

Ali

Esa

Voting Member

1

ACO Participant Representative

Esa M Ali MD PC

Accetta

Vito

Voting Member

1

Medicare Beneficiary

N/A

 

Key ACO clinical and administrative leadership:


Gary Wentzloff

ACO Executive

Michael Ziccardi

Medical Director

Kim Hamm

Compliance Officer

Kim Hamm

Quality Assurance/Improvement Officer

Associated committees and committee leadership:


Committee Name

Committee Leader Name and Position

Quality and Clinical Integration Committee

Sara Liter-Kuester, D.O., Chair

Utilization Management Committee

Michael Ziccardi, D.O., Chief Medical Officer, Chair

Finance Committee

David Mazurkiewicz,Senior Vice President, CFO, Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement
  • Networks of individual practices of ACO professionals
  • Partnerships or joint venture arrangements between hospitals and ACO professionals
  • Hospital employing ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • N/A

Shared Savings Distribution

  • N/A

Quality Performance Results

2016 Quality Performance Results:


ACO#

Measure Name

Rate

ACO Mean

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

N/A

79.9

ACO-2

CAHPS: How Well Your Providers Communicate

N/A

92.63

ACO-3

CAHPS: Patients' Rating of Provider

N/A

91.93

ACO-4

CAHPS: Access to Specialists

N/A

83.52

ACO-5

CAHPS: Health Promotion and Education

N/A

60

ACO-6

CAHPS: Shared Decision Making

N/A

75.28

ACO-7

CAHPS: Health Status/Functional Status

N/A

71.82

ACO-34

CAHPS: Stewardship of Patient Resources

N/A

27.52

ACO-8

Risk-Standardized, All Condition Readmission

N/A

14.7

ACO-35

Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)

N/A

18.17

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes

N/A

53.2

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure

N/A

75.23

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

N/A

59.81

ACO-9

Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)

N/A

9.27

ACO-10

Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 )

N/A

14.53

ACO-11

Percent of PCPs who Successfully Meet Meaningful Use Requirements

N/A

82.72

ACO-39

Documentation of Current Medications in the Medical Record

N/A

87.54

ACO-13

Falls: Screening for Future Fall Risk

N/A

64.04

ACO-14

Preventive Care and Screening: Influenza Immunization

N/A

68.32

ACO-15

Pneumonia Vaccination Status for Older Adults

N/A

69.21

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up

N/A

74.45

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

N/A

90.98

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

N/A

53.63

ACO-19

Colorectal Cancer Screening

N/A

61.52

ACO-20

Breast Cancer Screening

N/A

67.61

ACO-21

Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented

N/A

76.84

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

N/A

77.72

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

N/A

18.24

ACO-41

Diabetes: Eye Exam  

N/A

44.94

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

N/A

70.52

ACO-30

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

N/A

85.05

ACO-31

Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

N/A

88.67

ACO-33

Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)

N/A

79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.   

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.